Centene Withdraws 2025 Guidance Following $1.8 Billion Risk-Adjustment Shortfall

Preliminary actuarial findings of slower marketplace growth coupled with higher morbidity forced the company to pull its outlook, leaving it to reevaluate its pricing strategy